Elevance Health, Inc. - Common Stock (ELV) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
ELV on NYSE
Shares outstanding
225,970,109
Price per share
$322.92
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
201,041,086
Total reported value
$70,462,331,697
% of total 13F portfolios
0.05%
Share change
+5,121,798
Value change
+$1,834,713,913
Number of holders
1,511
Price from insider filings
$322.92
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Elevance Health, Inc. - Common Stock (ELV) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 10% $9,468,767,838 22,890,772 The Vanguard Group 30 Apr 2025
BlackRock, Inc. 7.8% $7,319,395,282 17,694,658 BlackRock, Inc. 31 Mar 2025

As of 31 Dec 2025, 1,511 institutional investors reported holding 201,041,086 shares of Elevance Health, Inc. - Common Stock (ELV). This represents 89% of the company’s total 225,970,109 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Elevance Health, Inc. - Common Stock (ELV) together control 57% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 10% 23,019,518 +0.09% 0.12% $8,069,492,034
BlackRock, Inc. 9% 20,402,634 -0.64% 0.12% $7,152,143,257
STATE STREET CORP 4.6% 10,341,466 -0.05% 0.12% $3,625,200,906
WELLINGTON MANAGEMENT GROUP LLP 3.7% 8,289,976 +25% 0.51% $2,906,051,086
PRICE T ROWE ASSOCIATES INC /MD/ 3.3% 7,446,185 +28% 0.28% $2,610,261,000
Sanders Capital, LLC 2.5% 5,750,865 -0.31% 2.3% $2,015,965,726
GEODE CAPITAL MANAGEMENT, LLC 2.3% 5,124,599 -0.38% 0.11% $1,797,008,992
Artisan Partners Limited Partnership 2.2% 5,032,751 +10% 2.7% $1,764,230,863
HARRIS ASSOCIATES L P 2.1% 4,794,445 +50% 2.1% $1,680,692,576
First Eagle Investment Management, LLC 1.8% 4,022,874 +0.61% 2.5% $1,410,218,523
Invesco Ltd. 1.7% 3,903,878 +50% 0.21% $1,368,504,544
NORGES BANK 1.3% 3,018,586 0.11% $1,058,165,322
Grantham, Mayo, Van Otterloo & Co. LLC 1.1% 2,531,090 +0.3% 2.3% $887,274,059
MORGAN STANLEY 1.1% 2,521,123 -6.1% 0.05% $883,780,825
Bank of New York Mellon Corp 1.1% 2,408,704 +79% 0.15% $844,371,095
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1% 2,360,858 -3.3% 0.27% $827,598,772
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 1% 2,347,771 -1.6% 0.17% $823,011,125
MANUFACTURERS LIFE INSURANCE COMPANY, THE 1% 2,275,342 +2.8% 0.66% $797,471,917
NORTHERN TRUST CORP 0.99% 2,231,428 -2% 0.1% $782,227,086
BANK OF AMERICA CORP /DE/ 0.98% 2,207,140 -15% 0.06% $773,712,932
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 0.91% 2,051,150 +0.28% 2.2% $719,030,633
BAILLIE GIFFORD & CO 0.88% 1,977,899 -8.7% 0.58% $693,352,495
Nuveen, LLC 0.87% 1,975,317 +1.4% 0.18% $692,447,371
Legal & General Group Plc 0.83% 1,866,369 -2.9% 0.15% $654,255,655
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.77% 1,737,722 +3.1% 0.09% $609,158,447

Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 201,041,086 $70,462,331,697 +$1,834,713,913 $350.55 1,511
2025 Q3 195,585,234 $63,213,130,342 -$3,312,621,564 $323.12 1,497
2025 Q2 204,604,844 $79,498,363,022 +$1,439,627,570 $388.96 1,568
2025 Q1 200,691,838 $87,287,919,928 -$2,163,798,151 $434.96 1,638
2024 Q4 206,213,996 $75,993,957,146 -$44,680,642 $368.90 1,579
2024 Q3 204,337,175 $106,108,060,305 -$2,056,527,998 $520.00 1,677
2024 Q2 207,236,343 $112,229,086,782 +$1,221,818,434 $541.86 1,694
2024 Q1 205,794,945 $106,687,848,409 -$1,247,923,452 $518.54 1,653
2023 Q4 207,752,105 $97,963,233,994 -$247,874,299 $471.56 1,648
2023 Q3 207,903,581 $90,580,448,880 -$638,821,702 $435.42 1,517
2023 Q2 209,210,262 $92,957,672,062 -$418,252,067 $444.29 1,513
2023 Q1 210,263,353 $96,683,749,324 -$1,143,379,932 $459.81 1,505
2022 Q4 212,710,438 $109,036,688,386 -$450,450,567 $512.97 1,535
2022 Q3 213,712,340 $97,144,686,967 -$43,691,666 $454.24 1,419
2022 Q2 213,631,648 $103,081,919,033 +$244,924,540 $482.58 1,427
2022 Q1 214,741,635 $105,507,397,690 +$476,326,109 $491.22 1,405
2021 Q4 213,774,296 $99,066,091,155 -$693,430,737 $463.54 1,356
2021 Q3 215,444,748 $80,367,417,712 -$316,844,753 $372.80 1,200
2021 Q2 216,259,288 $82,538,173,898 -$202,615,221 $381.80 1,218
2021 Q1 217,018,977 $77,891,055,351 -$10,123,479 $358.95 1,197
2020 Q4 216,717,748 $69,548,509,680 -$1,210,346,982 $321.09 1,152
2020 Q3 221,726,205 $59,513,110,228 -$812,067,541 $268.59 1,069
2020 Q2 224,433,586 $58,976,107,586 +$721,554,198 $262.98 1,087
2020 Q1 221,960,038 $50,395,003,088 -$269,286,785 $227.04 1,024
2019 Q4 222,498,992 $67,185,310,864 -$895,364,531 $302.03 1,091
2019 Q3 225,668,191 $54,151,556,112 -$548,766,172 $240.10 1,000
2019 Q2 227,616,918 $64,170,095,418 +$1,536,564,497 $282.21 1,017
2019 Q1 226,368,216 $64,895,946,969 -$571,793,174 $286.98 1,060
2018 Q4 228,485,511 $59,953,636,310 +$649,953,066 $262.63 981
2018 Q3 227,218,938 $62,202,902,147 -$82,133,140 $274.05 935
2018 Q2 227,862,596 $54,180,142,736 +$475,345,916 $238.03 917
2018 Q1 226,170,388 $49,620,249,094 +$136,418,805 $219.70 914
2017 Q4 226,383,870 $50,867,636,678 -$185,837,358 $225.01 904
2017 Q3 227,037,673 $43,110,236,091 -$979,896,912 $189.88 836
2017 Q2 234,666,772 $44,173,109,626 -$691,902,449 $188.13 842
2017 Q1 237,409,781 $39,276,632,137 +$4,215,665,646 $165.38 782
2016 Q4 236,826,614 $34,047,895,479 +$101,419,844 $143.77 774
2016 Q3 233,767,626 $29,277,751,316 -$472,226,246 $125.31 720
2016 Q2 237,434,049 $31,183,934,688 +$185,770,985 $131.34 747
2016 Q1 235,568,359 $32,735,981,567 -$98,831,773 $138.99 757
2015 Q4 236,580,508 $32,994,086,121 +$245,535,016 $139.44 752
2015 Q3 234,763,359 $32,864,234,259 +$972,586,432 $140.00 747
2015 Q2 227,776,038 $37,381,525,830 -$957,364,602 $164.14 771
2015 Q1 233,007,822 $35,964,678,637 -$91,145,105 $154.41 739
2014 Q4 234,612,259 $29,496,786,731 +$29,380,309,696 $125.67 697
2014 Q3 60,821 $7,275,000 $119.61 1
2014 Q2 60,821 $6,544,000 +$615,978 $107.59 1
2014 Q1 55,096 $5,484,000 +$2,384,868 $99.54 1